New Alzheimer’s Drug Shows Early Promise
Tuesday, October 11th, 2011MONDAY, Oct. 10 (HealthDay News) — An experimental Alzheimer’s disease drug, gantenerumab, may help lower levels of amyloid plaque in the brains of people with the disease, an early clinical trial indicates.
Read the original post:
New Alzheimer’s Drug Shows Early Promise